O'Connor K - Search Results

1

Organizational strategy use in obsessive-compulsive disorder.

Roth RM, Milovan DL, Baribeau J, O'Connor K, Todorov C. Roth RM, et al. Psychiatry Res. 2004 Oct 30;128(3):267-72. doi: 10.1016/j.psychres.2004.04.006. Psychiatry Res. 2004. PMID: 15541784

2

Speed and accuracy on tests of executive function in obsessive-compulsive disorder.

Roth RM, Baribeau J, Milovan DL, O'Connor K. Roth RM, et al. Brain Cogn. 2004 Apr;54(3):263-5. doi: 10.1016/j.bandc.2004.02.053. Brain Cogn. 2004. PMID: 15050790

3

Procedural and declarative memory in obsessive-compulsive disorder.

Roth RM, Baribeau J, Milovan D, O'Connor K, Todorov C. Roth RM, et al. J Int Neuropsychol Soc. 2004 Sep;10(5):647-54. doi: 10.1017/S1355617704105018. J Int Neuropsychol Soc. 2004. PMID: 15327712

4

Neuropsychological functioning in early- and late-onset obsessive-compulsive disorder.

Roth RM, Milovan D, Baribeau J, O'Connor K. Roth RM, et al. J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):208-13. doi: 10.1176/jnp.17.2.208. J Neuropsychiatry Clin Neurosci. 2005. PMID: 15939975 Clinical Trial.

5

A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.

Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K. Rasmussen S, et al. Int Clin Psychopharmacol. 1997 Nov;12(6):309-16. doi: 10.1097/00004850-199711000-00003. Int Clin Psychopharmacol. 1997. PMID: 9547132 Clinical Trial.

6

Overcoming treatment resistance in obsessive-compulsive disorder.

O'Connor K. O'Connor K. Acta Psychiatr Scand. 2005 Apr;111(4):257-60. doi: 10.1111/j.1600-0447.2004.00505.x. Acta Psychiatr Scand. 2005. PMID: 15740461 No abstract available.

7

Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review.

Golder S, Xu D, O'Connor K, Wang Y, Batra M, Hernandez GG. Golder S, et al. Among authors: o connor k. Drug Saf. 2025 Jan 9. doi: 10.1007/s40264-024-01505-6. Online ahead of print. Drug Saf. 2025. PMID: 39786481 Review.

8

Predicting purification process fit of monoclonal antibodies using machine learning.

Maier A, Cha M, Burgess S, Wang A, Cuellar C, Kim S, Rajan NS, Neyyan J, Sengupta R, O'Connor K, Ott N, Williams A. Maier A, et al. Among authors: o connor k. MAbs. 2025 Dec;17(1):2439988. doi: 10.1080/19420862.2024.2439988. Epub 2025 Jan 9. MAbs. 2025. PMID: 39782766 Free article.

9

The impact of a tailored nutrition intervention delivered for the duration of hospitalisation on daily energy delivery for patients with critical illness (INTENT): a phase II randomised controlled trial.

Ridley EJ, Bailey M, Chapman MJ, Chapple LS, Deane AM, Gojanovic M, Higgins AM, Hodgson CL, King VL, Marshall AP, Miller EG, McGuinness SP, Parke RL, Paul E, Udy AA; Australian, New Zealand Intensive Care Society Clinical Trials Group. Ridley EJ, et al. Crit Care. 2025 Jan 6;29(1):8. doi: 10.1186/s13054-024-05189-3. Crit Care. 2025. PMID: 39762887 Free PMC article. Clinical Trial.

10

NCHD handover in the acute mental health setting: a quality improvement initiative implementing an electronic handover tool.

Naxakis S, Wafer M, Gardezi S, Sadia A, Mujahid R, O'Connor K. Naxakis S, et al. Among authors: o connor k. BMJ Open Qual. 2025 Jan 6;14(1):e002978. doi: 10.1136/bmjoq-2024-002978. BMJ Open Qual. 2025. PMID: 39762058 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,921 results

Search Page

Filters